| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/04/2009 | CN100457106C Use of 1-deoxynojirimycin for preparing diabete and disney disease drug |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485647 2-aminoquinoline derivatives |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 01/29/2009 | WO2009014440A1 Inhibition of renal ischemia reperfusion injury by synthetic oligopeptides |
| 01/29/2009 | WO2009014150A1 Benzimidazole derivative |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2009013846A1 Pharmaceutical composition for amelioration of lower urinary tract symptom associated with prostatomegaly |
| 01/29/2009 | US20090030047 Peritoneum protecting agent |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090028974 Use of Botulinum Toxin Therapy for Treatment of Recalcitrant Voiding Dysfunction |
| 01/29/2009 | US20090028907 Botulinum toxin treatment |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | CA2697137A1 Pharmaceutical composition for amelioration of lower urinary tract symptoms associated with prostatomegaly |
| 01/29/2009 | CA2694216A1 Benzimidazole derivative |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | EP1670761B1 Tetrahydro-naphthalene and urea derivatives |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1470826B1 Decoy-containing pharmaceutical compositions for the treatment of aneurysms |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | CN101352536A Chinese medicine for curing nephritis |
| 01/28/2009 | CN101352535A Method for preparing Chinese medicine preparation for treating wind-heat symptoms type nephritis |
| 01/28/2009 | CN101352518A Chinese medicine for treating nephritis, kidney deficiency and renal failure and production method |
| 01/28/2009 | CN101352511A Medicated health-caring wine |
| 01/28/2009 | CN101352481A Method for preparing Chinese medicine desmodium anti-calculi fractionated extracts and uses thereof |
| 01/28/2009 | CN101352446A Compound and use for the treatment of benign prostatic hyperplasia and relative diseases |
| 01/28/2009 | CN101352421A Method for preparing basically non-crystalline type telmisartan |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/28/2009 | CN100455301C Therapeutical use of sophora flavescens or sophora subprostrated extracts |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | CA2489407C Lasofoxifene tablet and its coating |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2378803C Vitamin d3 analogs |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2283071C Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/22/2009 | WO2009012430A1 Sulfonamides as trpm8 modulators |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009010121A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/22/2009 | WO2009009907A1 Use of vasopressin-receptor agonists for the treatment of septic shock |
| 01/22/2009 | US20090023806 Aluminum-storage disease improving agent |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023742 Thiazolones for use as pi3 kinase inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023639 Methods of Treatment |
| 01/22/2009 | US20090023637 Methods for detecting and treating interstitial cystitis |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090022816 Storable, consumable pre-nascent iodine |
| 01/22/2009 | US20090022807 Drug formulations having inert sealed cores |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022712 Compositions and Methods for Inhibiting Leukocyte Function |
| 01/22/2009 | CA2693159A1 Sulfonamides as trpm8 modulators |
| 01/22/2009 | CA2691127A1 Phosphorylation of histone h3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/21/2009 | EP2017621A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation |
| 01/21/2009 | EP2017265A1 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 01/21/2009 | EP2016948A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 01/21/2009 | EP2016082A2 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 01/21/2009 | EP2016074A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016058A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2015768A1 Methods for treating kidney disorders |
| 01/21/2009 | EP2015766A1 Cyclised alpha-conotoxin peptides |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof |
| 01/21/2009 | CN101351462A 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1(VR1) activity |
| 01/21/2009 | CN101351215A A method of treatment |
| 01/21/2009 | CN101348760A Health preserving wine |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347580A Decoction medicament for treating hematuria induced by calculus |
| 01/21/2009 | CN101347573A Medicament for treating cirrhosis ascites and hepatorenal syndrome and preparation method thereof |
| 01/21/2009 | CN101347557A Medicament composition for refreshment and intelligence development and preparation and use thereof |
| 01/21/2009 | CN101347516A Method for preparing total free anthraquinones extract from rhubarb |
| 01/21/2009 | CN101347490A Extract of rape pollen with broken wall and purification method and use thereof |
| 01/21/2009 | CN101347465A Xylaria nigripes fermentation liquor powder and preparation and use |
| 01/21/2009 | CN101347454A Medicament for treating chronic renal failure and production method |
| 01/21/2009 | CN101347453A Application of attapulgite in pharmacy |
| 01/21/2009 | CN101347435A Medicament composition for treating nephroma of domestic bird |
| 01/21/2009 | CN101347423A 2-alkoxycarbonyl-3-phenylpropionate derivant-synthesis and uses thereof of novel ACE inhibitor |
| 01/21/2009 | CN101347422A Uses of salvianolic acid A in preventing and/or treating diabetes and complication |